M. G. Lewis

725 total citations
18 papers, 577 citations indexed

About

M. G. Lewis is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. G. Lewis has authored 18 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. G. Lewis's work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Virus-based gene therapy research (3 papers). M. G. Lewis is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Virus-based gene therapy research (3 papers). M. G. Lewis collaborates with scholars based in Canada, United States and United Kingdom. M. G. Lewis's co-authors include Geoffrey Rowden, Terry M. Phillips, Terence M. Phillips, R. D. Wilkinson, R. G. Olsen, G. Hamilton Fairley, Peter Alexander, R. L. Ikonopisov, J.W. Proctor and D. C. Bodenham and has published in prestigious journals such as Nature, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

M. G. Lewis

18 papers receiving 506 citations

Peers

Countries citing papers authored by M. G. Lewis

Since Specialization

Citations

This map shows the geographic impact of M. G. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Lewis more than expected).

Fields of papers citing papers by M. G. Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Lewis. The network helps show where M. G. Lewis may publish in the future.

Co-authorship network of co-authors of M. G. Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. Lewis. A scholar is included among the top collaborators of M. G. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. Lewis. M. G. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Chronic Feline Leukemia Virus Infection Alters Arachidonic Acid Proportions In Vivo and In Vitro 1993 ·Experimental Biology and Medicine ·(unknown), M. G. Lewis, R. G. Olsen, (unknown), L. A. Horrocks, J. L. Rojko	1
2	Phase I trial of mitomycin C immunoconjugates cocktails in human malignancies. 1989 ·PubMed ·Douglas Orr, R. K. Oldham, M. G. Lewis, (unknown), Shuen‐Kuei Liao, Kwong‐Sak Leung, (unknown), Robert Birch, Barry P. Avner	5
3	Adriamycin custom-tailored immunoconjugates in the treatment of human malignancies. 1988 ·PubMed ·R. K. Oldham, M. G. Lewis, Douglas Orr, Barry P. Avner, Shuen‐Kuei Liao, (unknown), Robert Birch	14
4	Suppression of in vitro Neutrophil Function by Feline Leukaemia Virus (FeLV) and Purified FeLV-p15E 1987 ·Journal of General Virology ·(unknown), M. G. Lewis, Lawrence E. Mathes, R. G. Olsen	33
5	Polymorphonuclear Leukocyte Dysfunction Associated with Feline Leukaemia Virus Infection 1986 ·Journal of General Virology ·M. G. Lewis, (unknown), (unknown), (unknown), R. G. Olsen	23
6	New approach to feline leukemia immunoprevention: soluble tumor cell vaccine. 1980 ·R. G. Olsen, M. G. Lewis, Lawrence E. Mathes, (unknown)	1
7	Malignant melanoma with renal dense deposits containing tumor antigens. 1979 ·PubMed ·Jean L. Olson, (unknown), M. G. Lewis, Kim Solez	28
8	Target Role of Langerhans Cells in Mycosis Fungoides: Transmission and Immuno‐Electron Microscopic Studies 1979 ·Journal of Cutaneous Pathology ·Geoffrey Rowden, Terry M. Phillips, M. G. Lewis, R. D. Wilkinson	74
9	Ia antigens on indeterminate cells of the epidermis: immunoelectronmicroscpic studies of surface antigens 1979 ·British Journal of Dermatology ·Geoffrey Rowden, Terry M. Phillips, M. G. Lewis	94
10	IMMUNE REACTIONS IN PATIENTS WITH BLADDER AND PROSTATIC CANCER¹ 1978 ·Australian and New Zealand Journal of Surgery ·Terence M. Phillips, M. G. Lewis	2
11	LANGERHANS CELLS: INVOLVEMENT IN THE PATHOGENESIS OF MYCOSIS FUNGOIDES 1976 ·British Journal of Dermatology ·Geoffrey Rowden, M. G. Lewis	92
12	Tumor-associated antigens in human malignant melanoma. 1973 ·PubMed ·M. G. Lewis, (unknown), Terence M. Phillips, (unknown)	23
13	Separation of Two Distinct Tumor-Associated Antibodies in the Serum of Melanoma Patients 1972 ·JNCI Journal of the National Cancer Institute ·M. G. Lewis, Terence M. Phillips	19
14	IMMUNOLOGICAL APPROACH TO CANCER THERAPY 1971 ·The Lancet ·M. G. Lewis, Terence M. Phillips	2
15	Possible Explanation for Loss of Detectable Antibody in Patients with Disseminated Malignant Melanoma 1971 ·Nature ·M. G. Lewis, Terence M. Phillips, (unknown), (unknown)	79
16	Autoimmunization with Irradiated Tumour Cells in Human Malignant Melanoma 1970 ·BMJ ·R. L. Ikonopisov, M. G. Lewis, (unknown), D. C. Bodenham, Terence M. Phillips, (unknown), J.W. Proctor, G. Hamilton Fairley, Peter Alexander	84
17	Differential diagnosis of malignant melanoma of feet in Uganda 1968 ·British journal of surgery ·M. G. Lewis, Joel Kiryabwire	2
18	Ovarian tumours in Ugandan Africans. 1967 ·PubMed ·(unknown), M. G. Lewis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact